Ron Bentsur
2019 - UroGen Pharma Ltd.
In 2019, Ron Bentsur earned a total compensation of $8.1K as Former Chief Executive Officer at UroGen Pharma Ltd., a 100% decrease compared to previous year.
Compensation breakdown
| Salary | $5,812 |
|---|---|
| Other | $2,326 |
| Total | $8,138 |
Bentsur received $5.8K in salary, accounting for 71% of the total pay in 2019.
Bentsur also received $2.3K in other compensation.
Rankings
In 2019, Ron Bentsur's compensation ranked 13,943rd out of 13,971 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,943 out of 13,971 | 0th |
Division Manufacturing | 5,690 out of 5,695 | 0th |
Major group Chemicals And Allied Products | 2,193 out of 2,194 | 0th |
Industry group Drugs | 1,879 out of 1,880 | 0th |
Industry Pharmaceutical Preparations | 1,391 out of 1,392 | 0th |
Pay ratio
| Ron Bentsur's Pay | $8,138 |
|---|---|
| Median Employee's Pay | $223,867 |
| Pay Ratio | to 1 |
In 2019, the annual total compensation of Ron Bentsur was $8,138.
The annual total compensation of the median employee at UroGen Pharma Ltd. was $223,867.
The ratio of Ron Bentsur's pay to the pay of median employee was therefore to one.
Source: SEC filing on April 29, 2020.
Bentsur's colleagues
We found four more compensation records of executives who worked with Ron Bentsur at UroGen Pharma Ltd. in 2019.